Suppliers / Zhejiang Candorly Pharmaceutical

Zhejiang Candorly Pharmaceutical

China Updated 9 July 2026

Zhejiang Candorly Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Taiping, Wenling City, China Not on file

What they file, and where

Molecule Regulators Docs
Clindamycin US FDA 1
Tenofovir Disoproxil US FDA 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Candorly Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability